Literature DB >> 22760792

Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer.

Sanaa Eissa1, Hanan Shehata, Amal Mansour, Mohamed Esmat, Omar El-Ahmady.   

Abstract

Diagnosis of bladder cancer is done by cystoscopy and cytology. In the last decade, many urine-based tests for bladder cancer have been developed and tested in different populations. Hence, it was relevant to assess the diagnostic significance of urinary hyaluronidase RNA and its enzyme activity in bladder cancer. Seventy patients with bladder cancer, 56 patients with benign bladder lesions, and 49 healthy controls were enrolled in this study. Voided urine samples from all subjects were used for estimation of urinary HAase RNA by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) and determination of its enzymatic activity by zymography. There was a significant difference in the mean ranks and positivity rates of HAase RNA expression (P < 0.01) and its enzymatic activity among the three investigated groups: malignant, benign, and normal (P < 0.01). In detecting bladder cancer, the sensitivity of urine cytology (42.83 %) was improved to 100 % when combined with urinary Hyal RNA or Hyal enzyme activity. Detection of urinary Hyal RNA and its enzyme activity is promising noninvasive tests with high sensitivities and specificities for detection of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22760792     DOI: 10.1007/s12032-012-0295-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  35 in total

1.  Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer.

Authors:  H T Pham; N L Block; V B Lokeshwar
Journal:  Cancer Res       Date:  1997-02-15       Impact factor: 12.701

2.  Increased bladder cancer risk among workers exposed to o-toluidine and aniline: a reanalysis.

Authors:  Tania Carreón; Misty J Hein; Susan M Viet; Kevin W Hanley; Avima M Ruder; Elizabeth M Ward
Journal:  Occup Environ Med       Date:  2009-11-02       Impact factor: 4.402

Review 3.  Bladder cancer in Africa: update.

Authors:  N G el-Mawla; M N el-Bolkainy; H M Khaled
Journal:  Semin Oncol       Date:  2001-04       Impact factor: 4.929

Review 4.  Endoscopic fluorescence diagnosis and laser treatment of transitional cell carcinoma of the bladder.

Authors:  D Frimberger; D Zaak; A Hofstetter
Journal:  Semin Urol Oncol       Date:  2000-11

Review 5.  Urine markers for bladder cancer surveillance: a systematic review.

Authors:  Bas W G van Rhijn; Henk G van der Poel; Theo H van der Kwast
Journal:  Eur Urol       Date:  2005-03-23       Impact factor: 20.096

Review 6.  Current bladder tumor tests: does their projected utility fulfill clinical necessity?

Authors:  V B Lokeshwar; M S Soloway
Journal:  J Urol       Date:  2001-04       Impact factor: 7.450

7.  Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests.

Authors:  Vinata B Lokeshwar; Grethchen L Schroeder; Marie G Selzer; Stefan H Hautmann; J Timothy Posey; Robert C Duncan; Roger Watson; Lyndon Rose; Steven Markowitz; Mark S Soloway
Journal:  Cancer       Date:  2002-07-01       Impact factor: 6.860

8.  Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression.

Authors:  V B Lokeshwar; B L Lokeshwar; H T Pham; N L Block
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

Review 9.  Epigenetic markers as promising prognosticators for bladder cancer.

Authors:  Young Kyoon Kim; Wun-Jae Kim
Journal:  Int J Urol       Date:  2008-08-20       Impact factor: 3.369

10.  Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis.

Authors:  S S Raab; J C Lenel; M B Cohen
Journal:  Cancer       Date:  1994-09-01       Impact factor: 6.860

View more
  5 in total

1.  Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.

Authors:  Sanaa Eissa; Marwa Matboli; Nada O E Essawy; Youssef M Kotb
Journal:  Tumour Biol       Date:  2015-07-03

Review 2.  Emerging roles for hyaluronidase in cancer metastasis and therapy.

Authors:  Caitlin O McAtee; Joseph J Barycki; Melanie A Simpson
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

Review 3.  Hyaluronan - a functional and structural sweet spot in the tissue microenvironment.

Authors:  James Monslow; Priya Govindaraju; Ellen Puré
Journal:  Front Immunol       Date:  2015-05-15       Impact factor: 7.561

Review 4.  The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer.

Authors:  Ranjeeta Thapa; George D Wilson
Journal:  Stem Cells Int       Date:  2016-04-21       Impact factor: 5.443

Review 5.  A Trickster in Disguise: Hyaluronan's Ambivalent Roles in the Matrix.

Authors:  Lena Bohaumilitzky; Ann-Kathrin Huber; Eva Maria Stork; Simon Wengert; Franziska Woelfl; Heike Boehm
Journal:  Front Oncol       Date:  2017-10-09       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.